CAS Number: 76824-35-6
H2-type histamine receptor antagonist with similar action than cimetidine. It is excreted in breast milk in clinically non-significant amount, much less than the dose administered to newborns and infants with gastroesophageal reflux disorders. Although it does not normally affect prolactin secretion, there have been several cases of galactorrhea. Still unknown whether it is due to Famotidine itself or to gastroesophageal reflux. Famotidine, Nizatidine and Roxatidine are excreted into milk but in less proportion than Cimetidine or Ranitidine, which have been proposed as alternative to during lactation.
CAS Number: 76824-35-6
Famotidine is used in newborn infants in higher dosages than are transmitted in breastmilk.[1] Famotidine would not be expected to cause any adverse effects in breastfed infants. No special precautions are required.
As usage of Famotidine | Ohm Laboratories Inc. is mostly safe while breastfeeding hence there should not be any concern. In case of any change in behavior or health of your baby you should inform your health care provider about usage of Famotidine | Ohm Laboratories Inc. else no further action is required.
Usage of Famotidine | Ohm Laboratories Inc. is safe for nursing mothers and baby, No worries.
No
US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday
UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700
Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week
Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week